Hannah Joseph Hospital FY26 revenue rises 18.73% to ₹92.05 Cr

Hannah Joseph Hospital reported a revenue of ₹92.05 Cr for the financial year ended March 31, 2026 (FY26), marking an increase of 18.73% from the previous year. The hospital's Profit After Tax (PAT) rose to ₹11.18 Cr, up from ₹7.21 Cr in FY25, reflecting a growth of 55.08%. The EBITDA for the period was recorded at ₹24.96 Cr, corresponding to a margin of 27.12%, while the Return on Equity Ratio (Average Equity) was noted at 15.00%.

The financial performance was driven by a strong operational showing, with the Average Revenue Per Occupied Bed (ARPOB) improving to ₹139 lakh in FY26 from ₹80 lakh in FY23. The hospital's total number of shares stood at 2.27 Cr, with a basic and diluted EPS of ₹6.32. The net worth of the company increased to ₹97.37 Cr as of March 31, 2026.

Financial Highlights

The company's revenue growth rate for FY26 was 18.73%, following a 22.27% growth in FY25. The PAT margin improved to 12.15% in FY26 from 9.30% in the previous year. The price to book value was recorded at ₹42.89.

Particulars	31st March 2026	31st March 2025	31st March 2024	31st March 2023
Revenue from operation	92.05	77.53	63.41	54.62
Revenue Growth Rate	18.73%	22.27%	16.09%
EBITDA	24.96	20.52	17.98	16.38
EBITDA margin	27.12%	26.47%	28.35%	29.99%
PAT	11.18	7.21	4.07	1.01
PAT margin	12.15%	9.30%	6.42%	1.85%
Net worth	97.37	51.94	45.71	34.55
Return on Equity Ratio (Avg Eq)	15.00%	14.77%	10.13%	3.14%
Basic / Diluted EPS (Rs.)	6.32	4.32	2.47	0.63
Total no.of shares (In crore)	2.27	1.67	1.67	1.63
Price to book value (Rs.)	42.89	31.10	27.38	21.13

Operational Metrics

The hospital reported a capacity utilization of 43.00% in FY26, up from 34.63% in FY23. The Average Bed Occupancy was 57 beds in FY26. Revenue per bed per day increased to ₹38,000 in FY26 from ₹22,000 in FY23.

KPI	FY23	FY24	FY25	FY26
Revenue from hospital (₹ Lakhs)	3,686	4,353	5,223	6,572
Average Bed Occupancy	46	49	57	57
Capacity Utilization (%)	34.63%	37.11%	42.49%	43.00%
Average Length of Stay	12	13	15	14
ARPOB (₹ Lakhs) per year	80	89	92	139
Revenue/Bed/Day (in Rupees)	22,000	24,000	25,000	38,000

Strategic Developments

Hannah Joseph Hospital outlined its opportunity for expansion into a Radiation Oncology Centre, leveraging its expertise in neurosciences. The company has acquired adjacent land for a dedicated oncology campus. The hospital also highlighted its technology edge, including the BrainLab Navigation System and DTI Fiber Tracking 3.0 (AI) for surgical precision.

Surgical growth was evident, with Neurosurgery cases increasing to 402 in FY26 from 303 in 2022-23. Orthopaedic and Trauma cases rose to 236 in FY26 from 59 in 2022-23. The overall surgical growth was reported at 16.80%.

Year	Neurosurgery	Orthopaedic/Trauma
2022-23	303	59
2023-24	344	78
2024-25	347	199
2025-26	402	236

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.26%	-11.61%	+11.95%	+60.59%	+60.59%	+60.59%

Hannah Joseph Hospital reported a 55.1% increase in net profit to ₹1,118.12 lakh for the financial year ended March 31, 2026, compared to ₹720.99 lakh in the previous year. Revenue from operations rose 18.7% to ₹9,205.17 lakh for FY26, up from ₹7,753.13 lakh in FY25. The Board of Directors recommended a final dividend of ₹2 per equity share, representing 20% of the face value, subject to shareholder approval at the ensuing Annual General Meeting.

The audited financial results were approved by the Board at its meeting held on May 29, 2026, under Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. M/s. A.V. Subramanian & Co., Chartered Accountants, issued an audit report with an unmodified opinion on the standalone financial results for the half year and financial year ended March 31, 2026.

Financial Performance

Total income for FY26 increased to ₹9,255.89 lakh from ₹7,790.05 lakh in the previous year. Profit before tax for the year stood at ₹1,603.48 lakh, a significant increase from ₹1,034.73 lakh in FY25. Earnings per share (EPS) for the year improved to ₹6.32 from ₹4.32 in the prior year.

Metric	FY26 (₹ in Lakhs)	FY25 (₹ in Lakhs)
Revenue from operations	9,205.17	7,753.13
Total Income	9,255.89	7,790.05
Total Expenses	7,652.41	6,755.32
Profit Before Tax	1,603.48	1,034.73
Net Profit	1,118.12	720.99

Capital Allocation and Dividend

The Board recommended a final dividend of ₹2 per equity share of face value ₹10 each for FY26. The company confirmed there was no deviation or variation in the utilization of proceeds raised through its Initial Public Offer (IPO) for the half year ended March 31, 2026. The total amount raised through the IPO was ₹4,200 lakh, with ₹753.29 lakh utilized as of March 31, 2026.

Corporate Governance

The Board re-appointed M/s. Pandiarajan.T & Co., Chartered Accountants, as the Internal Auditors for the financial year 2026-27. The company also confirmed it does not fall under the criteria of a 'Large Corporate' as specified in the SEBI Circular dated October 19, 2023, for the financial year ended March 31, 2026.